ENLIVEN THERAPEUTICS INC

Ticker: ELVN CUSIP: 29337E102 Class: Common Stock

CITADEL ADVISORS LLC's Holding History (CIK: 0001423053)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,424,344 Value ($000) $21,935 Avg Close $19.92 Range $15.14 - $24.64
Q3 2025
Shares 1,160,503 Value ($000) $23,755 Avg Close $20.16 Range $17.43 - $24.38
Q2 2025
Shares 1,470,424 Value ($000) $29,497 Avg Close $18.93 Range $13.30 - $24.11
Q1 2025
Shares 1,123,138 Value ($000) $22,103 Avg Close $21.52 Range $18.67 - $25.37
Q4 2024
Shares 1,738,532 Value ($000) $39,117 Avg Close $25.92 Range $21.43 - $30.03
Q3 2024
Shares 1,733,977 Value ($000) $44,286 Avg Close $23.16 Range $20.63 - $27.67
Q2 2024
Shares 2,307,814 Value ($000) $53,934 Avg Close $21.05 Range $15.96 - $26.00
Q1 2024
Shares 2,354,403 Value ($000) $41,414 Avg Close $15.34 Range $10.90 - $19.50
Q4 2023
Shares 2,394,448 Value ($000) $33,139 Avg Close $12.23 Range $9.80 - $15.41
Q3 2023
Shares 2,351,491 Value ($000) $32,121 Avg Close $16.84 Range $12.38 - $20.77
Q2 2023
Shares 2,296,210 Value ($000) $46,866 Avg Close $20.21 Range $17.15 - $23.98
Q1 2023
Shares 2,296,210 Value ($000) $50,287 Avg Close $20.34 Range $14.56 - $25.34